http://lookfordiagnosis.com
English
Spanish
Italian
Portuguese
French
Swedish
Ganetespib trial hints at survival benefit in lung adenocarcinoma
Tested in combination with docetaxel, the experimental drug appeared to improve overall and progression-free survival, compared with docetaxel alone, as second-line therapy for patients with advanced non–small cell adenocarcinoma of the lung, Dr ...
The Oncology Report - Wed, 16 Apr 2014 11:02

Survival greater in esophageal adenocarcinoma patients previously diagnosed ...
The small proportion of patients with esophageal adenocarcinoma previously diagnosed with Barrett's esophagus exhibited improved survival compared with those without a previous diagnosis in a recent study. Researchers in Northern Ireland conducted a ...
Healio - Thu, 10 Apr 2014 07:26

Acute pancreatitis may be predictor of pancreatic adenocarcinoma
Many patients with pancreatic adenocarcinoma initially presented with an episode of acute pancreatitis, and as long as 2 years elapsed between diagnoses, according to results of a retrospective study. The correlation appeared particularly strong in ...
Healio - Tue, 25 Mar 2014 07:03

Global Pancreatic Adenocarcinoma Therapeutics Market to Reach $1.2 billion in ...
Pancreatic Adenocarcinoma Therapeutics Market in Major Developed Markets to 2019 is a new pharma report announced by Reportstack. This report provides an estimation of the market size for 2012, along with market forecasts to 2019. It also covers ...
WhaTech - Mon, 07 Apr 2014 14:02

Pancreatic Adenocarcinoma Therapeutics Market in Major Developed Markets to ...
ResearchMoz.us include new market research report"Pancreatic Adenocarcinoma Therapeutics Market in Major Developed Markets to 2019 - Early Stage Pipeline Shows Diversity of Novel Targets though Commercial Impact Remains Distant " to its huge ...
Virtual-Strategy Magazine (press release) - Wed, 02 Apr 2014 01:26

Protein expression of programmed death 1 ligand 1 and ligand 2 independently ...
Background: The clinicopathologic characteristics of tumors expressing programmed death (PD-1) ligands (PD-Ls) PD-L1 or PD-L2 and their associations with common driver mutations in lung adenocarcinoma are not clearly defined, despite the progression ...
Dove Medical Press - Sun, 13 Apr 2014 19:48

Health Scan: Radio wave treatment instead of surgery for Barrett esophagus
The condition has a strong link to a deadly cancer called esophageal adenocarcinoma. In fact, Barrett esophagus is found in up to 15 percent of patients who seek medical care for heartburn. But Jerusalem's Shaare Zedek Medical Center now offers ...
Jerusalem Post - Sat, 19 Apr 2014 11:54



Nintedanib Improves PFS in Second-Line Docetaxel NSCLC Therapy
In patients with adenocarcinoma whose disease had progressed within nine months of the start of first-line treatment, median overall survival (OS) was significantly more improved in the docetaxel plus nintedanib group (n=206; 12.6 months; 95% CI, ...
Clinical Oncology News - Thu, 17 Apr 2014 08:45


1  2  3  4  5  6  7  8    ->

Last update: April 2009
Statistics